Welcome to LookChem.com Sign In|Join Free
  • or
3,6-Dichloropyridazine-4-carboxylic acid is an organic compound characterized by the presence of two chlorine atoms at the 3rd and 6th positions on a pyridazine ring, with a carboxylic acid group attached at the 4th position. This unique molecular structure endows it with specific chemical properties that make it a versatile building block in organic synthesis.

51149-08-7

Post Buying Request

51149-08-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51149-08-7 Usage

Uses

Used in Pharmaceutical Industry:
3,6-Dichloropyridazine-4-carboxylic acid is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its reactivity and functional groups allow for the creation of diverse drug candidates with potential therapeutic applications.
Used in Organic Synthesis:
3,6-Dichloropyridazine-4-carboxylic acid is used as a synthetic building block for the preparation of complex organic molecules. Its ability to undergo various chemical reactions, such as nucleophilic substitution and condensation, makes it a valuable component in the synthesis of advanced organic materials.
Used in the Synthesis of α-(halohetaroyl)-2-azahetarylacetonitriles:
3,6-Dichloropyridazine-4-carboxylic acid is used as a starting material for the synthesis of α-(halohetaroyl)-2-azahetarylacetonitriles. These compounds are of interest in the field of organic chemistry due to their potential applications in the development of new pharmaceuticals and other specialty chemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 51149-08-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,1,4 and 9 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 51149-08:
(7*5)+(6*1)+(5*1)+(4*4)+(3*9)+(2*0)+(1*8)=97
97 % 10 = 7
So 51149-08-7 is a valid CAS Registry Number.
InChI:InChI=1/C5H2Cl2N2O2/c6-3-1-2(5(10)11)4(7)9-8-3/h1H,(H,10,11)

51149-08-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L10418)  3,6-Dichloropyridazine-4-carboxylic acid, 98%   

  • 51149-08-7

  • 250mg

  • 121.0CNY

  • Detail
  • Alfa Aesar

  • (L10418)  3,6-Dichloropyridazine-4-carboxylic acid, 98%   

  • 51149-08-7

  • 1g

  • 267.0CNY

  • Detail
  • Alfa Aesar

  • (L10418)  3,6-Dichloropyridazine-4-carboxylic acid, 98%   

  • 51149-08-7

  • 5g

  • 1066.0CNY

  • Detail
  • Aldrich

  • (297755)  3,6-Dichloropyridazine-4-carboxylicacid  98%

  • 51149-08-7

  • 297755-5G

  • 2,018.25CNY

  • Detail

51149-08-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,6-Dichloropyridazine-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 3,6-dichloropyridazine-4-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51149-08-7 SDS

51149-08-7Relevant academic research and scientific papers

PYRIDAZINIL QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF TUMOURS

-

Page 53, (2010/02/09)

The invention concerns quinazoline derivatives of Formula (I) wherein Z is an O, S, SO, SO2, N(R2) or C(R2)(R3) group wherein each R2 or R3 group is hydrogen or (1-8C)alkyl, m is 1, 2 or 3, each R1 group has any of the meanings defined in the description, Ra is halogeno or (1-6C)alkoxy, Rb is halogeno or (1-6C)alkoxy, and Rc is hydrogen, halogeno, (1-8C)alkyl or (1-6C)alkoxy, or a pharmaceutically-acceptable salt thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumour disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 51149-08-7